Madison Square Garden Sports
MSGSNYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $388.63 Prior regular-session close from the quote source.
- $383.11–$392.56 Regular-session low and high so far today.
- 261.3K Regular-session shares traded · Oct 26, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $158.81–$392.56 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own MSGS if that scarcity translates into cash flow or value realization despite thin GAAP margins and leverage.
MSGS price history
Loading recent earnings…
Investment thesis
What must happen next
Scarcity of New York professional sports assets and live-fan demand keep giving MSGS monetization power across tickets, premium experiences, sponsorship, and media-related economics, so demand continues to convert into revenue.StrengtheningMateriality: High
GAAP annual revenue rose from $821.4 million in FY2022 to $1.1538 billion in FY2026. If this holds, the company has a durable top-line engine; if it breaks, the trophy-asset valuation rests on weakening commercial demand.
Watch: New York fans or corporate buyers resist further ticket, suite, or sponsorship price increases after weak team performance or consumer pressure.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual revenue rose from $821.4 million in FY2022 to $1.1538 billion in FY2026.
Open source ↗The company’s sports-asset pricing power must outrun player payroll, league costs, venue expenses, and other operating inflation; otherwise incremental revenue will not become owner earnings.HoldingMateriality: High
GAAP annual operating income remained positive at $28.9 million in FY2026. This determines whether MSGS is an earnings and cash-flow compounding business or merely a valuable asset with poor public-company profitability.
Watch: NBA or NHL salary-cap, luxury-tax, revenue-sharing, or player-compensation rules shift more economics from owners to labor.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating income remained positive at $28.9 million in FY2026.
Open source ↗Advance sales, sponsorship collections, league/media distributions, and live-event economics need to produce recurring operating cash flow sufficient to support the capital structure without relying on equity dilution or asset sales.HoldingMateriality: Medium
GAAP annual operating cash flow was positive at $62.7 million in FY2026. Cash generation is what lets shareholders wait for franchise-value realization; if it weakens, leverage and liquidity become the story.
Watch: Season-ticket or sponsorship cash collections weaken before revenue recognition, signaling lower forward demand.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating cash flow was positive at $62.7 million in FY2026.
Open source ↗MSGS’s balance sheet remains investable only if lenders and markets continue to underwrite the private-market value and cash-flow durability of its sports assets despite negative book equity.WeakeningMateriality: Medium
Cash increased from $144.6 million at FY2025 year-end to $164.5 million at FY2026 year-end. If financing access remains open, leverage can amplify equity value; if credit support weakens, shareholders face refinancing and control-risk pressure.
Watch: Credit markets reprice sports-franchise debt or demand tighter covenants because of higher rates or weaker media economics.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Cash increased from $144.6 million at FY2025 year-end to $164.5 million at FY2026 year-end.
Open source ↗Because GAAP earnings are thin and volatile relative to the asset story, public shareholders need disciplined capital allocation or a credible route to franchise-value realization rather than value leakage through control, costs, or financing.HoldingMateriality: Medium
GAAP diluted EPS moved from a loss of $0.93 in FY2025 to positive $0.32 in FY2026. The asset may be valuable, but the stock only compounds if that value accrues to minority shareholders.
Watch: Controlling-shareholder or related-party decisions prioritize strategic control, affiliated transactions, or empire-building over minority shareholder returns.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP diluted EPS moved from a loss of $0.93 in FY2025 to positive $0.32 in FY2026.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Scarcity of New York professional sports assets and live-fan demand keep giving MSGS monetization power across tickets, premium experiences, sponsorship, and media-related economics, so demand continues to convert into revenue. If this holds, the company has a durable top-line engine; if it breaks, the trophy-asset valuation rests on weakening commercial demand.
The company’s sports-asset pricing power must outrun player payroll, league costs, venue expenses, and other operating inflation; otherwise incremental revenue will not become owner earnings. This determines whether MSGS is an earnings and cash-flow compounding business or merely a valuable asset with poor public-company profitability.
Advance sales, sponsorship collections, league/media distributions, and live-event economics need to produce recurring operating cash flow sufficient to support the capital structure without relying on equity dilution or asset sales. Cash generation is what lets shareholders wait for franchise-value realization; if it weakens, leverage and liquidity become the story.
MSGS’s balance sheet remains investable only if lenders and markets continue to underwrite the private-market value and cash-flow durability of its sports assets despite negative book equity. If financing access remains open, leverage can amplify equity value; if credit support weakens, shareholders face refinancing and control-risk pressure.
Because GAAP earnings are thin and volatile relative to the asset story, public shareholders need disciplined capital allocation or a credible route to franchise-value realization rather than value leakage through control, costs, or financing. The asset may be valuable, but the stock only compounds if that value accrues to minority shareholders.
All standing thesis claims
Original report summary
that scarcity translates into cash flow or value realization despite thin GAAP margins and leverage.
Bull case and bear case
Bull case and bear case for Madison Square Garden Sports
Where the evidence on Madison Square Garden Sports disagrees: Mixed on the latest evidence (Oct 19, 2026). Of its 5 thesis points, 1 strengthening, 3 holding and 1 weakening.
Bull case: what the evidence supports
Scarcity of New York professional sports assets and live-fan demand keep giving MSGS monetization power across tickets, premium experiences, sponsorship, and media-related economics, so demand continues to convert into revenue.
The company’s sports-asset pricing power must outrun player payroll, league costs, venue expenses, and other operating inflation; otherwise incremental revenue will not become owner earnings.
Advance sales, sponsorship collections, league/media distributions, and live-event economics need to produce recurring operating cash flow sufficient to support the capital structure without relying on equity dilution or asset sales.
Because GAAP earnings are thin and volatile relative to the asset story, public shareholders need disciplined capital allocation or a credible route to franchise-value realization rather than value leakage through control, costs, or financing.
Bear case: what the evidence questions
MSGS’s balance sheet remains investable only if lenders and markets continue to underwrite the private-market value and cash-flow durability of its sports assets despite negative book equity.
Thesis-Break Engine
Thesis-break watch · Madison Square Garden Sports
Loading the break-condition record for Madison Square Garden Sports.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedEntered a material definitive agreement.
Madison Square Garden Sports filed an SEC 8-K on 2026-09-30: Entered a material definitive agreement. It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
Madison Square Garden Sports filed an SEC 8-K on 2026-09-22: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Madison Square Garden Sports filed an SEC 8-K on 2026-08-13: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- New York fans or corporate buyers resist further ticket, suite, or sponsorship price increases after weak team performance or consumer pressure.
- NBA or NHL salary-cap, luxury-tax, revenue-sharing, or player-compensation rules shift more economics from owners to labor.
- Season-ticket or sponsorship cash collections weaken before revenue recognition, signaling lower forward demand.
- Credit markets reprice sports-franchise debt or demand tighter covenants because of higher rates or weaker media economics.
- Controlling-shareholder or related-party decisions prioritize strategic control, affiliated transactions, or empire-building over minority shareholder returns.
MSGS news
Loading headlines…
Financial statements
MSGS income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
MSGS: quick answers
- Which well-known investors own MSGS?
- 1 of the 37 well-known funds tracked here reported MSGS shares in their latest 13F filing. By share of the fund's portfolio: Gates Foundation Trust (Bill Gates), 0.7%. Fund portfolios
MSGS in well-known investors’ portfolios
1 of 37 funds reported MSGS shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Bill GatesGates Foundation Trust | 0.69% | $238M | No change | Q2 2026 |
